Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OAT | P04181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17257754 | 0.56 | — | — | |
| SCHEMBL6014628 | 0.54 | — | — | |
| SCHEMBL20337501 | 0.54 | — | — | |
| SCHEMBL4017309 | 0.54 | — | — | |
| SCHEMBL23144983 | 0.53 | — | — | |
| Hydrochloric Acid SCHEMBL17193183 | 0.53 | — | — | |
| SCHEMBL18550841 | 0.50 | — | — | |
| SCHEMBL10413067 | 0.50 | OAT (0.32) | OAT | |
| SCHEMBL11953117 | 0.50 | CA12 (0.34) | — | |
| Hydrochloric Acid SCHEMBL16752785 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773740-B1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | UNIV SYDNEY (AU) | 2009-02-18 | — | — | EP | disclosed |
| US-20080032950-A1 | Neurologically-Active Compounds | THE UNIVERSITY OF SYDNEY (AU) | 2008-02-07 | — | — | US | disclosed |
| EP-1773740-A4 | NEUROLOGICALLY-ACTIVE COMPOUNDS | UNIV SYDNEY (AU) | 2007-09-19 | — | — | EP | disclosed |
| EP-1773740-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006000043-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080032950-A1 | Neurologically-Active Compounds | GABRE, GABRA5, GABRA1 | OAT 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.